Andrew Gobrial
About Andrew Gobrial
Andrew Gobrial is a Clinical Trial Manager at Bristol Myers Squibb with a background in oncology and genetics research.
Current Role at Bristol Myers Squibb
Andrew Gobrial serves as a Clinical Trial Manager at Bristol Myers Squibb. He commenced his role in January 2021. In his current capacity, he is responsible for overseeing and managing clinical trials, ensuring that they comply with regulatory requirements and are conducted efficiently. His work contributes to advancing medical research, particularly in oncology and genetics, aligning with his professional interests.
Previous Experience at DOCS
Before joining Bristol Myers Squibb, Andrew Gobrial worked at DOCS as a Clinical Trial Manager. From 2019 to 2020, he was on assignment with Bristol Myers Squibb in the United States. His role involved similar responsibilities, managing clinical trials and supporting the development of new pharmaceuticals.
Role at PRA Health Sciences
Between 2016 and 2019, Andrew Gobrial was employed at PRA Health Sciences as an In-House Clinical Research Associate (CRA). He was on assignment with Sanofi in Bridgewater, New Jersey. During his tenure, he played a crucial role in the internal monitoring and support of clinical trials, ensuring adherence to protocols and regulatory guidelines.
Project Support Specialist at BioClinica
From 2015 to 2016, Andrew Gobrial worked at BioClinica as a Project Support Specialist in the oncology sector. Based in Princeton, New Jersey, his responsibilities included supporting project management activities, facilitating communication between different stakeholders, and aiding in the efficient execution of clinical trials.
Education at Montclair State University
Andrew Gobrial attended Montclair State University, where he studied Biology, General. He earned a Bachelor of Science (B.S.) degree after three years of study from 2011 to 2014. His academic background provides a solid foundation for his career in clinical research and his specialization in oncology and genetics.